Antiproteases in preventing the invasive potential of pancreatic cancer cells
- PMID: 17625307
Antiproteases in preventing the invasive potential of pancreatic cancer cells
Abstract
The process of tumor progression and metastasis involves degradation of the extracellular matrix and is governed by an intricate balance of proteases, their activators and their inhibitors, in which malignant cells are permitted to infiltrate the adjacent structures and gain access to lymph and blood vessels. These proteases can be broadly categorized into three families: matrix metalloproteinases, serine proteinases and cysteine proteinases, all of which have all been implicated in these processes. The presence of neural invasion is often considered to be a poor prognostic sign; however, the cellular mechanisms underlying this propensity for perineural invasion are unknown. We recently researched the relationship between the glial cell line-derived neurotrophic factor and perineural invasion by human pancreatic cancer cells. We also confirmed that NF-kappa B is a part of the signaling pathway from the glial cell line-derived neurotrophic factor in human pancreatic cancer cells, and documented the inhibitory effect of gabexate mesilate, a well-known non-physiological synthetic serine protease inhibitor, for pancreatic cancer invasion. Recent studies on the role of proteases and protease inhibitors in pancreatic cancer invasion are also reviewed.
Similar articles
-
Action of antiproteases on pancreatic cancer cells.JOP. 2007 Jul 9;8(4 Suppl):479-87. JOP. 2007. PMID: 17625304
-
A novel role of interleukin-13 receptor alpha2 in pancreatic cancer invasion and metastasis.Cancer Res. 2009 Nov 15;69(22):8678-85. doi: 10.1158/0008-5472.CAN-09-2100. Epub 2009 Nov 3. Cancer Res. 2009. PMID: 19887609
-
Tumor-derived pancreatic stellate cells promote pancreatic cancer cell invasion through release of thrombospondin-2.J Surg Res. 2009 Sep;156(1):155-60. doi: 10.1016/j.jss.2009.03.040. Epub 2009 May 3. J Surg Res. 2009. PMID: 19592030
-
Proteases and their inhibitors in human brain tumours: a review.Anticancer Res. 1997 Nov-Dec;17(6B):4151-62. Anticancer Res. 1997. PMID: 9428349 Review.
-
Protein C and its inhibitor in malignancy.Semin Thromb Hemost. 2007 Oct;33(7):667-72. doi: 10.1055/s-2007-991534. Semin Thromb Hemost. 2007. PMID: 18000793 Review.
Cited by
-
[Advances in the molecular mechanisms of perineural invasion in salivary adenoid cystic carcinoma].Hua Xi Kou Qiang Yi Xue Za Zhi. 2018 Apr 1;36(2):204-211. doi: 10.7518/hxkq.2018.02.017. Hua Xi Kou Qiang Yi Xue Za Zhi. 2018. PMID: 29779285 Free PMC article. Chinese.
-
Novel therapeutic compounds for prostate adenocarcinoma treatment: An analysis using bioinformatic approaches and the CMap database.Medicine (Baltimore). 2020 Dec 18;99(51):e23768. doi: 10.1097/MD.0000000000023768. Medicine (Baltimore). 2020. PMID: 33371142 Free PMC article.
-
Proteomic biomarkers in body fluids associated with pancreatic cancer.Oncotarget. 2018 Mar 27;9(23):16573-16587. doi: 10.18632/oncotarget.24654. eCollection 2018 Mar 27. Oncotarget. 2018. PMID: 29662668 Free PMC article. Review.
-
Perineural invasion and associated pain in pancreatic cancer.Nat Rev Cancer. 2011 Sep 23;11(10):695-707. doi: 10.1038/nrc3131. Nat Rev Cancer. 2011. PMID: 21941281 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical